Gepotidacin and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Gepotidacin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect your heart's rhythm. Buprenorphine (like Belbuca or Butrans) is a pain and opioid-dependence medicine, and gepotidacin (Blujepa) is an antibiotic. Each one can slightly stretch out a part of your heartbeat called the QT interval. When you take them together, that effect can add up and, in rare cases, lead to an irregular heartbeat.
Right now this concern is mostly theoretical, meaning it is based on how the drugs work rather than lots of reported cases. Still, it is worth taking seriously. The good news is your care team can manage this easily by checking your heart and bloodwork if both are needed. Please talk with your pharmacist or doctor before combining them.
Effect: Additive QTc interval prolongation with concomitant buprenorphine and gepotidacin. Neither is a prodrug here; the concern is pharmacodynamic additivity, and gepotidacin exposure may also increase.
- Direction: Increased risk of QT prolongation and potential for torsades de pointes.
- Evidence: Theoretical; onset unspecified.
- Severity: Major.
Management: Avoid concomitant use where possible. If unavoidable, correct electrolyte abnormalities (K+, Mg2+, Ca2+) and obtain a baseline ECG plus follow-up ECGs during treatment as needed. Consider a non-QT-prolonging antibiotic alternative if clinically appropriate.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Do not combine gepotidacin with medications known to prolong the QT interval, since this raises gepotidacin exposure along with the likelihood of QTc interval prolongation. When gepotidacin use cannot be prevented, check for and correct any serum electrolyte imbalances, and obtain an ECG before dosing and throughout treatment as necessary1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Keep taking both medicines as prescribed and do not stop either on your own. Because this pair can add to QT prolongation, your care team will decide how best to handle it.
- Your team may avoid using them together and pick a different antibiotic when possible.
- If both are truly needed, they may check and correct your electrolytes (like potassium and magnesium) and order an ECG before and during treatment.
Tell your pharmacist or doctor that you take buprenorphine before starting gepotidacin, and report any fainting, dizziness, or heart palpitations right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Gepotidacin and Buprenorphine together?
Combining buprenorphine and gepotidacin can add up to prolong the QT interval, so this pairing is best avoided; if both are needed, your team will check electrolytes and monitor your heart with ECGs. Speak with your pharmacist or doctor before combining them. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Gepotidacin and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Gepotidacin and Buprenorphine interaction managed?
Keep taking both medicines as prescribed and do not stop either on your own. Because this pair can add to QT prolongation, your care team will decide how best to handle it. Your team may avoid using them together and pick a different antibiotic when possible. If both are truly needed, they may check and correct your electrolytes (like potassium and magnesium) and order an ECG before and during tre… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Gepotidacin or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BLUJEPA oral tablets, gepotidacin oral tablets. GlaxoSmithKline (per FDA), Durham, NC, 2025. DailyMed
Keep reading about Buprenorphine
Keep reading about Gepotidacin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist